Search
Arcturus Therapeutics Holdings Inc
ARCTAdd to Watchlist
7.410USD
+1.330+21.88%
Close 08-07 16:00（ET）Quotes delayed by 15 min
210.61MMarket Cap
LossP/E TTM
More Details of Arcturus Therapeutics Holdings Inc Company
Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.
Arcturus Therapeutics Holdings Inc Profile
Ticker SymbolARCT
Company nameArcturus Therapeutics Holdings Inc
IPO dateMay 22, 2013
CEOPayne (Joseph E)
Number of employees174
Security typeOrdinary Share
Fiscal year-endMay 22
Address10285 Science Center Drive
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121-1132
Phone18589002660
Websitehttps://arcturusrx.com/
Ticker SymbolARCT
IPO dateMay 22, 2013
CEOPayne (Joseph E)
Company Executives of Arcturus Therapeutics Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph E. Payne
Mr. Joseph E. Payne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.48M
--
Dr. Padmanabh Chivukula
Dr. Padmanabh Chivukula
Chief Operating Officer, Chief Scientific Officer
Chief Operating Officer, Chief Scientific Officer
435.33K
--
Dr. Magda Marquet, Ph.D.
Dr. Magda Marquet, Ph.D.
Independent Director
Independent Director
24.94K
--
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. James F. Barlow
Mr. James F. Barlow
Independent Director
Independent Director
--
--
Dr. Edward W. Holmes, M.D.
Dr. Edward W. Holmes, M.D.
Independent Director
Independent Director
--
--
Mr. Lance Kurata
Mr. Lance Kurata
Chief Legal Officer
Chief Legal Officer
--
--
Dr. Adm. Jing L. Marantz, M.D., Ph.D.
Dr. Adm. Jing L. Marantz, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. John H. Markels, Ph.D.
Dr. John H. Markels, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph E. Payne
Mr. Joseph E. Payne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.48M
--
Dr. Padmanabh Chivukula
Dr. Padmanabh Chivukula
Chief Operating Officer, Chief Scientific Officer
Chief Operating Officer, Chief Scientific Officer
435.33K
--
Dr. Magda Marquet, Ph.D.
Dr. Magda Marquet, Ph.D.
Independent Director
Independent Director
24.94K
--
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. James F. Barlow
Mr. James F. Barlow
Independent Director
Independent Director
--
--
Dr. Edward W. Holmes, M.D.
Dr. Edward W. Holmes, M.D.
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Arcturus Therapeutics Holdings Inc?
The top five shareholders of Arcturus Therapeutics Holdings Inc are: Mr. Joseph E. Payne
How many institutions hold shares of Arcturus Therapeutics Holdings Inc (ARCT)?
As of 2026Q1, 391 institutions hold shares of Arcturus Therapeutics Holdings Inc, with a combined market value of approximately 23.00M, accounting for 80.91% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -6433375.00.